These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 37758852)
21. A new scoring system to predict Kawasaki disease with coronary artery lesions. Hua W; Ma F; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F Clin Rheumatol; 2019 Apr; 38(4):1099-1107. PubMed ID: 30523553 [TBL] [Abstract][Full Text] [Related]
22. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children]. Deng YC; Wang X; Tang XC; Huang CZ; Yang J; Mo LY Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):927-31. PubMed ID: 26412172 [TBL] [Abstract][Full Text] [Related]
23. [Clinical features of Kawasaki disease complicated by macrophage activation syndrome: an analysis of 27 cases]. Wen YN; Chen J; Liu F; Ding Y; Yin W Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jun; 25(6):572-578. PubMed ID: 37382125 [TBL] [Abstract][Full Text] [Related]
24. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions]. Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276 [TBL] [Abstract][Full Text] [Related]
25. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method. Satoh K; Wakejima Y; Gau M; Kiguchi T; Matsuda N; Takasawa R; Takasawa K; Nishioka M; Shimohira M Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337 [TBL] [Abstract][Full Text] [Related]
26. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system]. Xie L; Zhou C; Wang R; Xiao T; Shen J; Huang M Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):34-9. PubMed ID: 25748402 [TBL] [Abstract][Full Text] [Related]
27. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study. Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965 [TBL] [Abstract][Full Text] [Related]
28. [Predicting value of thrombospondin-2 for coronary artery dilatation in patients with Kawasaki disease]. Song RX; Li XH; Zhang T; Cui XD; Fu J Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):259-63. PubMed ID: 27055423 [TBL] [Abstract][Full Text] [Related]
29. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions. Xia Y; Tian X; Li Q; Wang G; Li C; Yang J Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297 [TBL] [Abstract][Full Text] [Related]
30. The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease. Zhang JY; Peng H; Gong ST; Zeng YM; Huang M; Liu PH; Wang LT; Dong GQ J Int Med Res; 2021 Mar; 49(3):300060521994925. PubMed ID: 33729859 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for coronary artery lesions in children with Kawasaki disease. Duan J; Jiang H; Lu M Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395 [TBL] [Abstract][Full Text] [Related]
32. Plasma MASP-1 concentration and its relationship to recovery from coronary artery lesion in children with Kawasaki disease. Song RX; Zou QM; Li XH; Xu NP; Zhang T; Fu J; Cui XD Pediatr Res; 2016 Feb; 79(2):301-7. PubMed ID: 26536449 [TBL] [Abstract][Full Text] [Related]
33. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions. Rong X; Jia L; Hong L; Pan L; Xue X; Zhang C; Lu J; Jin Z; Qiu H; Wu R; Chu M J Cardiovasc Transl Res; 2017 Feb; 10(1):1-8. PubMed ID: 27981487 [TBL] [Abstract][Full Text] [Related]
34. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease. Sun Y; Liu J; Geng Z; Tao Y; Zheng F; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F Pediatr Rheumatol Online J; 2020 Mar; 18(1):23. PubMed ID: 32183825 [TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies in children with Kawasaki disease]. Zhao JM; Wang XH Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):740-4. PubMed ID: 25008884 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of dual-source CT in Kawasaki disease. Chao BT; Wang XM; Wu LB; Chen J; Cheng ZP; Wu DW; Duan YH Chin Med J (Engl); 2010 Mar; 123(6):670-4. PubMed ID: 20368084 [TBL] [Abstract][Full Text] [Related]
37. Study design and rationale to assess Doxycycline Efficacy in preventing coronary Artery Lesions in children with Kawasaki disease (DEAL trial) - A phase II clinical trial. Bratincsak A; Limm-Chan BN; Nerurkar VR; Ching LL; Reddy VD; Lim E; Shohet RV; Melish ME Contemp Clin Trials; 2018 Feb; 65():33-38. PubMed ID: 29313803 [TBL] [Abstract][Full Text] [Related]
38. [Application of selective coronary angiography in children with Kawasaki disease complicated with severe coronary artery lesion]. He L; Liu F; Huang GY; Wu L; Chu C; Lu Y Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):108-112. PubMed ID: 30695884 [No Abstract] [Full Text] [Related]
39. Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease. Yu HR; Kuo HC; Huang EY; Liang CD; Hwang KP; Lin IC; Sheen JM; Wang TJ; Wang CL; Yang KD Pediatr Cardiol; 2010 Nov; 31(8):1151-6. PubMed ID: 20711835 [TBL] [Abstract][Full Text] [Related]
40. Retrospective analysis of clinical characteristics and related influencing factors of Kawasaki disease. Cai WJ; Ding SG Medicine (Baltimore); 2022 Dec; 101(52):e32430. PubMed ID: 36596080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]